International Cannabis Weekly: 455

UK MEDICAL CANNABIS MARKET GROWING FASTER THAN EXPECTED AS PATIENT NUMBERS AND PRESCRIBING CONTINUE TO ACCELERATE

In 2025, the UK imported more than 30,000 kilograms of cannabis-based medicinal products (CBPMs), more than doubling for the second consecutive year, new data from Prohibition Partners shows.

READ MORE  »

MEDICAL CANNABIS IMPORTS CONTINUE TO OUTPACE UK CULTIVATION

READ MORE »

NINE OF TEN HIGHEST-VOLUME UK CBPM PRESCRIBERS ARE PHARMACISTS, DATA SHOWS

READ MORE »

• Curaleaf Laboratories and Herdade das Barrocas partner to bring HDB medical cannabis products back to the UK market.
• Sanity Group and Astrasana form strategic partnership to expand medical cannabis access in Switzerland.
• France sets July deadline for medical cannabis regulations as study links treatment to lower opioid use.
• Czech Republic introduces new rules for cannabis possession and home cultivation from 2026 onwards.
• Patient groups urge ministers to reconsider proposed restrictions on over-the-counter CBD products.
• Plant-derived cannabis pain treatment receives FDA breakthrough therapy designation in major regulatory milestone.

LEARN MORE »

• States collected nearly $15 billion in legal cannabis tax revenue over the past five years, new report finds.
• Alaska law allowing eligible residents to seal cannabis convictions takes effect without governor’s signature.
• Nebraska officials approve the start of medical cannabis cultivation under newly established programme.
• US Supreme Court rules in favour of cannabis user charged over unlawful firearm possession.
• Minnesota cannabis testing laboratory shuts down citing concerns over the state’s regulatory framework.
• Growing numbers of older adults are using cannabis as researchers investigate the reasons behind the trend.
• Legal cannabis tax revenue in the United States surpasses $28 billion since the first adult-use market launched.
• Massachusetts legal cannabis market continues to evolve amid changing regulatory and commercial challenges.

• Canadian hemp industry calls on regulators to adopt one percent THC limit and wider policy reforms.
• Cannabis Council of Canada suspends operations amid ongoing challenges facing the legal industry.
• Victoria cannabis consumption lounge seeks local support for proposed Oak Bay Junction location.
•  Nova Scotia cannabis sales continue to rise despite uncertainty over losses to the illicit market.
• Alberta’s festival cannabis retail model is emerging as a leading example for the industry.
• Lakehead University study warns Canada’s cannabis tracking systems are failing to keep pace with the market.

• Argentine university launches new medicinal cannabis course offering official academic certification.
• Mendoza introduces regulations allowing the medicinal use of cannabis treatments for animals.
• Cannabis decriminalisation for personal use remains on hold as Chile delays legal reforms.
• Mexico’s unresolved legal framework continues to create uncertainty for the country’s cannabis industry.

• Ananda Pharma confirms CBD drug safety as clinical trials for chronic pain move closer.
• Indian state advances industrial hemp rollout with greater focus on value chain development.
• Thailand opens public consultation on proposed new cannabis legislation and regulatory framework.
• New Zealand cannabis clinic launches CBD product through medicinal cannabis concession programme.

• Illegal cannabis stores continue operating openly across South Africa despite enforcement concerns.
• IM Cannabis signs letter of intent to sell its European operations as strategic restructuring continues.